Article
NYU puts forward cancer test to help predict the success and toxicity of checkpoint inhibitor immunotherapies
Rating:
0.0
Views:
47
Likes:
1
Library:
1
Researchers at New York University (NYU) have developed a single test they say can help determine which patients are most likely to see their cancer return after treatment with immunotherapies as w | Researchers at NYU have developed a single test they say can help determine which patients may see their cancer return after treatment with immunotherapies, as well as who may be at risk for severe side effects.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value